Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 4, Issue 8, 2007, Pages 686-691

  Camp, Pat G ^a,b   Goring, Sarah M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Epidemiology; Gender bias; Women

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; STEROID;

ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; DEPRESSION; DISEASE SURVEILLANCE; DYSPNEA; ENVIRONMENTAL FACTOR; FATIGUE; GENDER; HEALTH BEHAVIOR; HUMAN; PULMONARY REHABILITATION; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; SOCIAL CLASS; SPUTUM; SYMPTOM;

ADRENAL CORTEX HORMONES; BRONCHODILATOR AGENTS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; POPULATION SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SEX FACTORS; SMOKING CESSATION;

EID: 37349083826     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200706-081SD     Document Type: Article

References (59)

1. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001;46:798-825.
2. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
3. O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Can Respir J 2003;10(Suppl A):11A-65A.
4. A Report of the Task Force on the NIH's Women's Health Research Agenda for the Twenty-first Century. Bethesda, MD: National Institutes of Health; 1999. NIH Publication No. 99-4385.
5. Kauffmann F, Becklake M. Maladies obstructives pulmonaires: un paradigme de la complexite des differences de sante entre hommes et femmes. In: Saurel-Cubizolles MJ, Blondell B, editors. La Sante des Femmes. Paris: Flammarion, Medecine et Sciences; 1996.
6. Watson L, Vestbo J, Postma DS, Decramer M, Rennard S, Kiri VA, Vermeire PA, Soriano JB. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004;98:1207-1213.
7. de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest 2005;128:2012-2016.
8. Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Camargo CA. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med 2005;12:1173-1179.
9. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F. Allegra L, Centanni S. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006;100:1767-1774.
10. Gift AG, Shepard CE. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ? J Obstet Gynecol Neonatal Nurs 1999;28:201-208.
11. Katzura H, Yamada K, Wakagayashi R, Kida K. Gender-associated differences in dyspnea and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2007;12:427-432.
12. Low G, Gutman G. Examining the role of gender in health-related quality of life: perceptions of older adults with chronic obstructive pulmonary disease. J Gerontol Nurs 2006;21:42-49.
13. Hesselink AE, van der Windt PA, Penninx BW, Wijnhoven HA, Twisk JW, Bouter LM, van Eijk JT. What predicts change in pulmonary function and quality of life in asthma or COPD? J Asthma 2006;43:513-519.
14. Stahl E, Lindberg A, Jansson SA, Ronmark E, Svensson K, Andersson F, Lofdahl CG, Lundback B. Health-related quality of life is related to COPD severity. Health Qual Life Outcomes 2005;9:56.
15. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119:1691-1695.
16. Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martin A, Chapman KR. Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care [Spanish]. Arch Bronconeumol 2006;42:3-8.
17. Anthonisen NR, Wooldrage K, Manfreda J. Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases. Can Respir J 2005;12:69-74.
18. Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J 2006;28:319-322.
19. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med 2004;25:331-341.
20. Panday S, Reddy SP, Ruiter RAC, Bergstrom E, de Vries H. Nicotine dependence and withdrawal symptoms among occasional smokers. J Adolesc Health 2007;40:144-150.
21. Ben-Laken Cohen S, Paré PD, Man SFP, Sin DD. The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 2007;176:113-120.
22. Scharf D, Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analysis of clinical trials of bupropion SR. Addiction 2004;99:1462-1469.
23. Gritz ER, Nielsen IR, Brooks LA. Smoking cessation and gender: the influence of physiological, psychological, and behavioral factors. J Am Med Womens Assoc 1996;51:35-42.
24. Bjornson W, Rand C, Connett JE, Lindgren P, Nides M, Pope F, Buist AS, Hoppe-Ryan C, O'Hara P. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 1995;85:223-230.
25. Sherman SE, Fu SS, Joseph AM, Lanto AB, Yano EM. Gender differences in smoking cessation services received among veterans. Womens Health Issues 2005;15:126-133.
26. Wagena EJ, Zeegers MP, van Schayck CP, Wouters EF. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease. Drug Saf 2003;26:381-403.
27. Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, Canessa PA, Neri M, Melani AS. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med 2006;19:127-136.
28. Jimenez-Garcia R, Arinez-Fernandez MC, Garcia-Carballo M, Hernandez-Barrera V, de Miguel AG, Carrasco-Garrido P. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine 2005;23:3679-3686.
29. Arinez-Fernandez MC, Carrasco-Garrido P, Garcia-Carballo M, Hernandez-Barrera V, de Miguel AG, Jiménez-Garcia R. Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain. Hum Vaccin 2006;2:99-104.
30. Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P. Gender does not influence the response to the combination of salmeterol and fluticasone proprionate in COPD. Respir Med 2004;98:1045-1050.
31. Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, Cornelissen PJ. Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium. Eur Respir J 2002;19:209-216.
32. Ikeda A, Nishimura K, Koyama H, Izumi T. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. Chest 1995;107:401-405.
33. Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999;115:957-965.
34. Dahl R, Greefhorst LA, Nowak D, Nonikov V, Byrne AM, Thomson MH, Till D, Della Cioppa G. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:778-784.
35. Man WD, Mustfa N, Nikoletou D, Kaul S, Hart N, Rafferty GF, Donaldson N, Polkey MI, Moxham J. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax 2004;59:471-476.
36. O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-840.
37. Watson L, Schouten JP, Lofdahl CG, Pride NB, Laitinen LA, Postma DS. Predictors of COPD symptoms: does the sex of the patient matter? Eur Respir J 2006;28:311-318.
38. Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 2002;166:1563-1566.
39. Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999;340:1948-1953.
40. Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brondum E, Nieminen MM, Aine T, Bakke P, Janson C. Mortality in COPD patients discharged from hospital: the role of treatment and comorbidity. Respir Res 2006;7:109.
41. Raine R, Goldfrad C, Rowan K, Black N. Influence of patient gender on admission to intensive care. J Epidemiol Community Health 2002;56:418-423.
42. Patil SP, Krishnan JA, Lechtzin MD, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003;163:1180-1186.
43. Sunyer J, Anto JM, McFarlane D, Domingo A, Tobias A, Barcelo MA, Munoz A. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:851-856.
44. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006;11:188-195.
45. Fabbri L, Pauwels RA, Hurd SS. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary; updated 2003. COPD 2004;1:105-141.
46. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004;10:98-103.
47. Foy CG, Rejeski WJ, Berry MJ, Zaccaro D, Woodard CM. Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest 2001;119:70-76.
48. Haggerty MC, Stockdale-Woolley R, Zuwallack R. Functional status in pulmonary rehabilitation participants. J Cardiopulm Rehabil 1999;19:35-42.
49. Mannino D, Homa D, Akinbami L, Ford E, Redd S. Chronic obstructive pulmonary disease surveillance: United States 1971-2000. MMWR CDC Surveill Summ 2002;51:1-16.
50. Canadian Institute for Health Information; Canadian Lung Association; Health Canada; Statistics Canada. Respiratory disease in Canada. Ottawa, Canada: Health Canada; 2001.
51. Chaudhry M, Camp PG, Abbott W, Levy RD, Sin DD, Road JD, Tregillus V, Platt H. A snapshot of COPD care in British Columbia. Vancouver, Canada: Ministry of Health, Government of British Columbia; 2005.
52. Lacasse Y, Montori VM, Lanthier C, Maltais F. The validity of diagnosing chronic obstructive pulmonary disease from a large administrative database. Can Respir J 2005;12:251-256.
53. Becklake MR, Kauffmann F. Gender differences in airway behavior over the human life span. Thorax 1999;54:1119-1138.
54. Ofir D, McBride I, Webb KA, Dudgeon DJ, O'Donnell DE. Gender differences in exertional dyspnea with advancing age [abstract]. Proc Am Thorac Soc 2006;3:A224.
55. Sin DD, Sharpe HM, Cowie RL, Man SF. Spirometric findings among school-aged First Nations children on a reserve: a pilot study. Can Respir J 2004;11:45-48.
56. Soriano JB, Maier WC, Visick G, Pride N. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol 2001;17:1075-1080.
57. Rawson NSB, D'Arcy C. Assessing the validity of diagnostic information in administrative health utilization data: experience in Saskatchewan. Pharmacoepidemiol Drug Saf 1998;7:389-398.
58. McKnight J, Scott A, Menzies D, Bourbeau J, Blais L, Lemiere C. A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol 2005;58:206-208.
59. Watson L, Vonk JM, Lofdahl CG, Pride NB, Pauwels RA, Laitinen LA, Schouten JP, Postma DS. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the EUROSCOP study. Respir Med 2006;100:746-753.